Clinical Trial Update: Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - General [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Kovanaze nasal spray with Articaine for pulpal anesthesia in maxillary teeth has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apical Periodontitis
• Dental Caries

Drugs mentioned

• Articaine (articaine)
• Kovanaze (tetracaine hydrochloride and oxymetazoline hydrochloride nasal spray)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Caries,Dental, Apical Periodontitis | Phase 2 | Status: WITHDRAWN